Adobe Announces $25 Billion Buyback as It Moves to Reassure Investors on AI Strategy
Adobe unveiled a $25 billion share buyback program as it seeks to boost investor confidence while expanding its AI-driven product suite.
Follow the breakthroughs and disruptions driving the technology industry. From artificial intelligence and advanced chips to new digital platforms and corporate strategies, this section covers how leading tech companies innovate and shape the future of business. We highlight major product launches, research advances and market moves to give readers a clear view of where technology and commerce intersect.
Adobe unveiled a $25 billion share buyback program as it seeks to boost investor confidence while expanding its AI-driven product suite.
Apple will appoint hardware chief John Ternus as CEO, with Tim Cook transitioning to executive chairman, marking a major leadership shift at the tech giant.
Kering outlined an ambitious plan to revive Gucci and double profits, aiming to restore growth after a prolonged slowdown in its flagship brand.
Snap will lay off about 1,000 employees, or 16% of its workforce, as part of a cost-cutting plan tied to AI-driven efficiency and profitability goals.
Novo Nordisk has partnered with OpenAI to enhance its drug discovery efforts using advanced AI tools, aiming to accelerate identification of new treatments.
Blue Origin has developed a system to extract oxygen from lunar soil, a breakthrough that could support future Moon bases. The technology also produces usable metals...
Elon Musk is set to launch XChat on April 17, introducing an encrypted messaging platform integrated with X. The app will include calls, file sharing, and...
Alibaba confirmed it is behind a viral AI video model topping global leaderboards. The reveal highlights its growing role in the AI race.
OpenAI has raised $122 billion in a record-breaking funding round to accelerate AI development. The deal comes as expectations grow for a future public offering.
Apple’s third co-founder Ron Wayne says he still owns a 10% stake in the company despite exiting shortly after its founding. The claim has reignited debate...
Eli Lilly will pay up to $2.75 billion to bring AI-developed drugs from Insilico Medicine to market. The deal highlights growing momentum in AI-driven drug discovery.
OpenAI is shutting down its Sora video generation model, citing undisclosed reasons. Reports suggest the product may have been costing up to $15 million per day...